title: Role of PARP-1 in prostate cancer.
abstract: Poly (ADP-ribose) polymerase-1 (PARP-1) is an enzyme that catalyzes the covalent attachment of polymers of ADP-ribose (PAR) moieties on itself and its target proteins. PARP1 activity is frequently deregulated in various cancers and therefore it has emerged as a new drug target for cancer therapy. The role of PARP-1 in DNA repair has been well documented and BRCA mutations are implicated for determining the sensitivity to PARP inhibitors. Recent studies also point to a role of PARP-1 in transcription regulation which may contribute to oncogenic signaling and cancer progression. Given that efficacy of PARP inhibitors are also seen in patients not harboring BRCA mutations, some other mechanisms might also be involved. In the present review, we highlight the mechanisms by which PARP-1 regulates gene expression in prostate cancer and provide an overview of the ongoing clinical trials using PARP inhibitors in various cancers including prostate cancer.
authors.affiliation: Department of Pharmacology, University of Maryland School of Medicine Baltimore, Maryland, 21201.
authors.forename: Dhanraj
authors.initials: D
authors.lastname: Deshmukh
authors.affiliation: Department of Pharmacology, University of Maryland School of Medicine Baltimore, Maryland, 21201.
authors.forename: Yun
authors.initials: Y
authors.lastname: Qiu
keywords: PAR; PARP-1; prostate cancer